[SYRS] YoY Quarter Result on 30-Jun-2023 [#Q2]

Stock
[SYRS] Syros Pharmaceuticals, Inc.
Announcement Date
08-Aug-2023
Financial Year
2023
Quarter
30-Jun-2023 [#Q2]
Profit Trend
QoQ- -142.95%
YoY- -3.03%
Quarter Report
SYRS's Result
SYRS's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Revenue 0 2,833 6,276 5,162 3,188 462 375 -
PBT -23,327 -36,258 -34,481 -22,490 -17,196 -19,455 -14,047 8.81%
Tax 0 1,278 712 969 0 0 0 -
NP -23,327 -36,258 -35,193 -22,490 -17,196 -19,455 -14,047 8.81%
Tax Rate - - - - - - - -
Total Cost 23,327 39,091 41,469 27,652 20,384 19,917 14,422 8.33%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
NP Margin 0.00 -1,279.84 -560.76 -435.68 -539.40 -4,211.04 -3,745.87 -
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
EPS -0.59 -1.30 -5.51 -3.60 -3.76 -4.67 -4.27 -28.07%
EPS Diluted -0.59 -1.30 -5.51 -3.58 -3.76 -4.67 -4.27 -28.07%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.